-
1
-
-
0005076913
-
Cancers, nutrition and food
-
World Cancer Research Fund & American Institute for Cancer Research , 1st ed, Chapt 4.18, American Institute for Cancer Research, Washington, pp
-
World Cancer Research Fund & American Institute for Cancer Research (1997): Cancers, nutrition and food. Nutrition and the Prevention of Cancer: a global perspective. 1st ed, Chapt 4.18, American Institute for Cancer Research, Washington, pp338-361
-
(1997)
Nutrition and the Prevention of Cancer: A global perspective
, pp. 338-361
-
-
-
2
-
-
0021720335
-
Advances in the etiology of urothelial cancer
-
Morrison AS (1984): Advances in the etiology of urothelial cancer. Urol Clin North Am 11: 557-566
-
(1984)
Urol Clin North Am
, vol.11
, pp. 557-566
-
-
Morrison, A.S.1
-
4
-
-
0024420537
-
Risk of bladder cancer by source and type of tobacco exposure: A case-control study
-
Burch JD, Rohan TE, Howe GR, Risch HA, Hill GB, Steele R & Miller AB (1989): Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer 44: 622-628
-
(1989)
Int J Cancer
, vol.44
, pp. 622-628
-
-
Burch, J.D.1
Rohan, T.E.2
Howe, G.R.3
Risch, H.A.4
Hill, G.B.5
Steele, R.6
Miller, A.B.7
-
5
-
-
0033767107
-
Genetic factors in chemically-induced transitional cell bladder cancer
-
Filiadis I & Hrouda D (2000): Genetic factors in chemically-induced transitional cell bladder cancer. BJU Int 86: 794-801
-
(2000)
BJU Int
, vol.86
, pp. 794-801
-
-
Filiadis, I.1
Hrouda, D.2
-
7
-
-
0025992864
-
Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes
-
Guengerich FP & Shimada T (1991): Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 4: 391-407
-
(1991)
Chem Res Toxicol
, vol.4
, pp. 391-407
-
-
Guengerich, F.P.1
Shimada, T.2
-
8
-
-
0028136926
-
Metabolic activation and carcinogen-DNA adduct detection in human larynx
-
Degawa M, Stern SJ, Martin MV, Guengerich FP, Fu PP, Ilett KF, Kaderlik RK & Kadlubar FF (1994): Metabolic activation and carcinogen-DNA adduct detection in human larynx. Cancer Res 54: 4915-4919
-
(1994)
Cancer Res
, vol.54
, pp. 4915-4919
-
-
Degawa, M.1
Stern, S.J.2
Martin, M.V.3
Guengerich, F.P.4
Fu, P.P.5
Ilett, K.F.6
Kaderlik, R.K.7
Kadlubar, F.F.8
-
9
-
-
0027963634
-
The expression and environmental regulation of P450 enzymes in human placenta
-
Pasanen M & Pelkonen O (1994): The expression and environmental regulation of P450 enzymes in human placenta. Crit Rev Toxicol 24: 211-229
-
(1994)
Crit Rev Toxicol
, vol.24
, pp. 211-229
-
-
Pasanen, M.1
Pelkonen, O.2
-
10
-
-
0030872306
-
Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons
-
Boffetta P, Jourenkova N & Gustavsson P (1997): Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 8: 444-472
-
(1997)
Cancer Causes Control
, vol.8
, pp. 444-472
-
-
Boffetta, P.1
Jourenkova, N.2
Gustavsson, P.3
-
11
-
-
0017831789
-
Genetic differences in microsomal electron transport: The Ah locus
-
Nebert DW (1978): Genetic differences in microsomal electron transport: the Ah locus. Methods Enzymol 52: 226-240
-
(1978)
Methods Enzymol
, vol.52
, pp. 226-240
-
-
Nebert, D.W.1
-
12
-
-
0021718042
-
Aryl hydrocarbon hydroxylase induction levels in patients with malignant tumors associated with smoking
-
Korsgaard R, Trell E, Simonsson BG, Stiksa G, Janzon L, Hood B & Oldbring J (1984): Aryl hydrocarbon hydroxylase induction levels in patients with malignant tumors associated with smoking. J Cancer Res Clin Oncol 108: 286-289
-
(1984)
J Cancer Res Clin Oncol
, vol.108
, pp. 286-289
-
-
Korsgaard, R.1
Trell, E.2
Simonsson, B.G.3
Stiksa, G.4
Janzon, L.5
Hood, B.6
Oldbring, J.7
-
13
-
-
0025914145
-
Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene
-
Hayashi S, Watanabe J, Nakachi K & Kawajiri K (1991): Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem (Tokyo) 110: 407-411
-
(1991)
J Biochem (Tokyo)
, vol.110
, pp. 407-411
-
-
Hayashi, S.1
Watanabe, J.2
Nakachi, K.3
Kawajiri, K.4
-
14
-
-
0030028660
-
The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene
-
Kiyohara C, Hirohata T & Inutsuka S (1996): The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn J Cancer Res 87: 18-24
-
(1996)
Jpn J Cancer Res
, vol.87
, pp. 18-24
-
-
Kiyohara, C.1
Hirohata, T.2
Inutsuka, S.3
-
15
-
-
0004316754
-
Metabolic polymorphisms and susceptibility to cancer
-
IARC , P Vineis, M Malats, M Lang, A d'Errico, N Caporaso, J Cuzick & P Boffetta ed, Lyon 510pp
-
IARC (1999): Metabolic polymorphisms and susceptibility to cancer. 148 (P Vineis, M Malats, M Lang, A d'Errico, N Caporaso, J Cuzick & P Boffetta ed). IARC Sci, Lyon 510pp
-
(1999)
IARC Sci
, vol.148
-
-
-
16
-
-
0023663556
-
Msp-1 polymorphism detected with a cDNA probe for the P-450I family on chromosome 15
-
Spurr NK, Gough AC, Stevenson K & Wolf CR (1987): Msp-1 polymorphism detected with a cDNA probe for the P-450I family on chromosome 15. Nucleic Acids Res 15: 5901
-
(1987)
Nucleic Acids Res
, vol.15
, pp. 5901
-
-
Spurr, N.K.1
Gough, A.C.2
Stevenson, K.3
Wolf, C.R.4
-
17
-
-
0025236927
-
Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene
-
Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N & Watanabe J (1990): Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 263: 131-133
-
(1990)
FEBS Lett
, vol.263
, pp. 131-133
-
-
Kawajiri, K.1
Nakachi, K.2
Imai, K.3
Yoshii, A.4
Shinoda, N.5
Watanabe, J.6
-
19
-
-
0028904630
-
Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients
-
Katoh T, Inatomi H, Nagaoka A & Sugita A (1995): Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients. Carcinogenesis 16: 655-657
-
(1995)
Carcinogenesis
, vol.16
, pp. 655-657
-
-
Katoh, T.1
Inatomi, H.2
Nagaoka, A.3
Sugita, A.4
-
20
-
-
0029815779
-
Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk
-
Brockmoller J, Cascorbi I, Kerb R & Roots I (1996): Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 56: 3915-3925
-
(1996)
Cancer Res
, vol.56
, pp. 3915-3925
-
-
Brockmoller, J.1
Cascorbi, I.2
Kerb, R.3
Roots, I.4
-
21
-
-
0031715322
-
Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: P53 mutations and polymorphism of carcinogen-metabolising enzymes
-
Bringuier PP, McCredie M, Sauter G, Bilous M, Stewart J, Mihatsch MJ, Kleihues P & Ohgaki H (1998): Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: p53 mutations and polymorphism of carcinogen-metabolising enzymes. Int J Cancer 79: 531-536
-
(1998)
Int J Cancer
, vol.79
, pp. 531-536
-
-
Bringuier, P.P.1
McCredie, M.2
Sauter, G.3
Bilous, M.4
Stewart, J.5
Mihatsch, M.J.6
Kleihues, P.7
Ohgaki, H.8
-
22
-
-
0028336794
-
Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: Absence of mutation prescribing the phenotype in the CYP1A2 gene
-
Nakajima M, Yokoi T, Mitsutani M, Shin S, Kadlubar FF & Kamataki T (1994): Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene. Cancer Epidemiol Biomarkers Prev 3: 413-421
-
(1994)
Cancer Epidemiol Biomarkers Prev
, vol.3
, pp. 413-421
-
-
Nakajima, M.1
Yokoi, T.2
Mitsutani, M.3
Shin, S.4
Kadlubar, F.F.5
Kamataki, T.6
-
23
-
-
0029068118
-
Metabolic polymorphisms and carcinogen-DNA adduct formation in human populations
-
Kaderlik KR & Kadlubar FF (1995): Metabolic polymorphisms and carcinogen-DNA adduct formation in human populations. Pharmacogenetics 5: 108-117
-
(1995)
Pharmacogenetics
, vol.5
, pp. 108-117
-
-
Kaderlik, K.R.1
Kadlubar, F.F.2
-
24
-
-
0028695177
-
CYP1A2 activity as a risk factor for bladder cancer
-
Lee SW, Jang IJ, Shin SG, Lee KH, Yim DS, Kim SW, Oh SJ & Lee SH (1994): CYP1A2 activity as a risk factor for bladder cancer. J Korean Med Sci 9: 482-489
-
(1994)
J Korean Med Sci
, vol.9
, pp. 482-489
-
-
Lee, S.W.1
Jang, I.J.2
Shin, S.G.3
Lee, K.H.4
Yim, D.S.5
Kim, S.W.6
Oh, S.J.7
Lee, S.H.8
-
25
-
-
0027285481
-
Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens
-
Bartsch H, Malaveille C, Friesen M, Kadlubar FF & Vineis P (1993): Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer 29: 1199-1207
-
(1993)
Eur J Cancer
, vol.29
, pp. 1199-1207
-
-
Bartsch, H.1
Malaveille, C.2
Friesen, M.3
Kadlubar, F.F.4
Vineis, P.5
-
26
-
-
0028556579
-
Expression of N-acetyltransferase (NAT) in cultured human uroepithelial cells
-
Kloth MT, Gee RL, Messing EM & Swaminathan S (1994): Expression of N-acetyltransferase (NAT) in cultured human uroepithelial cells. Carcinogenesis 15: 2781-2787
-
(1994)
Carcinogenesis
, vol.15
, pp. 2781-2787
-
-
Kloth, M.T.1
Gee, R.L.2
Messing, E.M.3
Swaminathan, S.4
-
27
-
-
0032751791
-
Detection of three genetic polymorphisms in the 5′-flanking region and intron 1 of human CYP1A2 in the Japanese population
-
Chida M, Yokoi T, Fukui T, Kinoshita M, Yokota J & Kamataki T (1999): Detection of three genetic polymorphisms in the 5′-flanking region and intron 1 of human CYP1A2 in the Japanese population. Jpn J Cancer Res 90: 899-902
-
(1999)
Jpn J Cancer Res
, vol.90
, pp. 899-902
-
-
Chida, M.1
Yokoi, T.2
Fukui, T.3
Kinoshita, M.4
Yokota, J.5
Kamataki, T.6
-
28
-
-
0032929010
-
Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: Effect on the CYP1A2 inducibility in humans
-
Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M & Kamataki T (1999): Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem 125: 803-808
-
(1999)
J Biochem
, vol.125
, pp. 803-808
-
-
Nakajima, M.1
Yokoi, T.2
Mizutani, M.3
Kinoshita, M.4
Funayama, M.5
Kamataki, T.6
-
29
-
-
0032908778
-
Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine
-
Sachse C, Brockmoller J, Bauer S & Roots I (1999): Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 47: 445-449
-
(1999)
Br J Clin Pharmacol
, vol.47
, pp. 445-449
-
-
Sachse, C.1
Brockmoller, J.2
Bauer, S.3
Roots, I.4
-
30
-
-
0035316570
-
Five novel natural allelic variants- 951A>C, 1042G>A (D348N), 1156A>T (I386F), 1217G>A (C406Y) and 1291C>T (C431Y)- of the human CYP1A2 gene in a French Caucasian population
-
Chevalier D, Cauffiez C, Allorge D, Lo-Guidice JM, Lhermitte M, Lafitte JJ & Broly F (2001): Five novel natural allelic variants- 951A>C, 1042G>A (D348N), 1156A>T (I386F), 1217G>A (C406Y) and 1291C>T (C431Y)- of the human CYP1A2 gene in a French Caucasian population. Hum Mutat 17: 355-356
-
(2001)
Hum Mutat
, vol.17
, pp. 355-356
-
-
Chevalier, D.1
Cauffiez, C.2
Allorge, D.3
Lo-Guidice, J.M.4
Lhermitte, M.5
Lafitte, J.J.6
Broly, F.7
-
31
-
-
0025022689
-
The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes
-
Yamano S, Tatsuno J & Gonzalez FJ (1990): The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29: 1322-1329
-
(1990)
Biochemistry
, vol.29
, pp. 1322-1329
-
-
Yamano, S.1
Tatsuno, J.2
Gonzalez, F.J.3
-
32
-
-
0032939647
-
Expression of CYP2A genes in human liver and extrahepatic tissues
-
Koskela S, Hakkola J, Hukkanen J, Pelkonen O, Sorri M, Saranen A, Anttila S, Fernandez-Salguero P, Gonzalez F & Raunio H (1999): Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem Pharmacol 57: 1407-1413
-
(1999)
Biochem Pharmacol
, vol.57
, pp. 1407-1413
-
-
Koskela, S.1
Hakkola, J.2
Hukkanen, J.3
Pelkonen, O.4
Sorri, M.5
Saranen, A.6
Anttila, S.7
Fernandez-Salguero, P.8
Gonzalez, F.9
Raunio, H.10
-
33
-
-
8044258385
-
Role of human cytochrome P4502A6 in C-oxidation of nicotine
-
Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T & Kuroiwa Y (1996): Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 24: 1212-1217
-
(1996)
Drug Metab Dispos
, vol.24
, pp. 1212-1217
-
-
Nakajima, M.1
Yamamoto, T.2
Nunoya, K.3
Yokoi, T.4
Nagashima, K.5
Inoue, K.6
Funae, Y.7
Shimada, N.8
Kamataki, T.9
Kuroiwa, Y.10
-
34
-
-
0030885491
-
A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes
-
Messina ES, Tyndale RF & Sellers EM (1997): A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 282: 1608-1614
-
(1997)
J Pharmacol Exp Ther
, vol.282
, pp. 1608-1614
-
-
Messina, E.S.1
Tyndale, R.F.2
Sellers, E.M.3
-
36
-
-
0026934672
-
Interindividual variability of coumarin 7-hydroxylation in healthy volunteers
-
Rautio A, Kraul H, Kojo A, Salmela E & Pelkonen O (1992): Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Pharmacogenetics 2: 227-233
-
(1992)
Pharmacogenetics
, vol.2
, pp. 227-233
-
-
Rautio, A.1
Kraul, H.2
Kojo, A.3
Salmela, E.4
Pelkonen, O.5
-
37
-
-
0027984350
-
Interindividual variability of coumarin 7-hydroxylation in a Turkish population
-
Iscan M, Rostami H, Iscan M, Guray T, Pelkonen O & Rautio A (1994): Interindividual variability of coumarin 7-hydroxylation in a Turkish population. Eur J Clin Pharmacol 47: 315-318
-
(1994)
Eur J Clin Pharmacol
, vol.47
, pp. 315-318
-
-
Iscan, M.1
Rostami, H.2
Iscan, M.3
Guray, T.4
Pelkonen, O.5
Rautio, A.6
-
38
-
-
0033546744
-
CYP2A6 gene deletion reduces susceptibility to lung cancer
-
Miyamoto M, Umetsu Y, Dosaka-Akita H, Sawamura Y, Yokota J, Kunitoh H, Nemoto N, Sato K, Ariyoshi N & Kamataki T (1999): CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochem Biophys Res Commun 261: 658-660
-
(1999)
Biochem Biophys Res Commun
, vol.261
, pp. 658-660
-
-
Miyamoto, M.1
Umetsu, Y.2
Dosaka-Akita, H.3
Sawamura, Y.4
Yokota, J.5
Kunitoh, H.6
Nemoto, N.7
Sato, K.8
Ariyoshi, N.9
Kamataki, T.10
-
39
-
-
0033584449
-
The significance of the homozygous CYP2A6 deletion on nicotine metabolism: A new genotyping method of CYP2A6 using a single PCR-RFLP
-
Kitagawa K, Kunugita N, Katoh T, Yang M & Kawamoto T (1999): The significance of the homozygous CYP2A6 deletion on nicotine metabolism: a new genotyping method of CYP2A6 using a single PCR-RFLP. Biochem Biophys Res Commun 262: 146-151
-
(1999)
Biochem Biophys Res Commun
, vol.262
, pp. 146-151
-
-
Kitagawa, K.1
Kunugita, N.2
Katoh, T.3
Yang, M.4
Kawamoto, T.5
-
40
-
-
0033659142
-
Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C
-
Ariyoshi N, Takahasi Y, Miyamoto M et al (2000): Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C. Pharamacogenetics 10: 687-693
-
(2000)
Pharamacogenetics
, vol.10
, pp. 687-693
-
-
Ariyoshi, N.1
Takahasi, Y.2
Miyamoto, M.3
-
41
-
-
0036667958
-
Characterization of a genotype previously designated as CYP2A6 D-type: CYP2A6*4B, another entire gene deletion allele of the CYP2A6 gene in Japanese
-
Ariyoshi N, Sekine H, Saito K & Kamataki T (2002): Characterization of a genotype previously designated as CYP2A6 D-type: CYP2A6*4B, another entire gene deletion allele of the CYP2A6 gene in Japanese. Pharmacogenetics 12: 501-504
-
(2002)
Pharmacogenetics
, vol.12
, pp. 501-504
-
-
Ariyoshi, N.1
Sekine, H.2
Saito, K.3
Kamataki, T.4
-
42
-
-
0036334087
-
Genetic polymorphisms of CYP2A6 and CYP2E1 with tobacco smoking is not associated with risk of urothelial cancer
-
Tsukino H, Kuroda Y, Nakao H, Imai H, Osada Y, Inatomi H, Kitagawa K, Kawamoto T & Katoh T (2002): Genetic polymorphisms of CYP2A6 and CYP2E1 with tobacco smoking is not associated with risk of urothelial cancer. Environmental Health and Preventive Medicine 7: 129-131
-
(2002)
Environmental Health and Preventive Medicine
, vol.7
, pp. 129-131
-
-
Tsukino, H.1
Kuroda, Y.2
Nakao, H.3
Imai, H.4
Osada, Y.5
Inatomi, H.6
Kitagawa, K.7
Kawamoto, T.8
Katoh, T.9
-
43
-
-
0034792584
-
Clinical relevance of genetic polymorphisms in the human CYP2C subfamily
-
Goldstein JA (2001): Clinical relevance of genetic polymorphisms in the human CYP2C subfamily, Br J Clin Pharmacol 52: 349-355
-
(2001)
Br J Clin Pharmacol
, vol.52
, pp. 349-355
-
-
Goldstein, J.A.1
-
44
-
-
0023193252
-
Genetic predisposition to bladder cancer: Ability to hydroxylate debrisoquine and mephenytoin as risk factors
-
Kaisary A, Smith P, Jaczq E, McAllister CB, Wilkinson GR, Ray WA & Branch RA (1987): Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors. Cancer Res 47: 5488-5493
-
(1987)
Cancer Res
, vol.47
, pp. 5488-5493
-
-
Kaisary, A.1
Smith, P.2
Jaczq, E.3
McAllister, C.B.4
Wilkinson, G.R.5
Ray, W.A.6
Branch, R.A.7
-
45
-
-
0028260641
-
The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans
-
De Morais SM, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA & Goldstein JA (1994): The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem 269: 15419-15422
-
(1994)
J Biol Chem
, vol.269
, pp. 15419-15422
-
-
De Morais, S.M.1
Wilkinson, G.R.2
Blaisdell, J.3
Nakamura, K.4
Meyer, U.A.5
Goldstein, J.A.6
-
46
-
-
0742286803
-
Cytochrome P450 2D6: Overview and update on pharmacology, genetics, biochemistry
-
Zanger UM, Raimundo S & Eichelbaum M (2004): Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn-Schmiedberg's Arch Pharamacol 369: 23-37
-
(2004)
Naunyn-Schmiedberg's Arch Pharamacol
, vol.369
, pp. 23-37
-
-
Zanger, U.M.1
Raimundo, S.2
Eichelbaum, M.3
-
47
-
-
0029558569
-
Metabolic polymorphisms and cancer susceptibility
-
Smith G, Stanley LA, Sim E, Strange RC & Wolf CR (1995): Metabolic polymorphisms and cancer susceptibility. Cancer Surv 25: 27-65
-
(1995)
Cancer Surv
, vol.25
, pp. 27-65
-
-
Smith, G.1
Stanley, L.A.2
Sim, E.3
Strange, R.C.4
Wolf, C.R.5
-
48
-
-
0026019485
-
The development of a human cell line stably expressing human CYP3A4: Role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3
-
Crespi CL, Penman BW, Steimel DT, Gelboin HV & Gonzalez FJ (1991): The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3. Carcinogenesis 12: 355-359
-
(1991)
Carcinogenesis
, vol.12
, pp. 355-359
-
-
Crespi, C.L.1
Penman, B.W.2
Steimel, D.T.3
Gelboin, H.V.4
Gonzalez, F.J.5
-
50
-
-
0024817873
-
Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer
-
Horai Y, Fujita K & Ishizaki T (1989): Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer. Eur J Clin Pharmacol 37: 581-587
-
(1989)
Eur J Clin Pharmacol
, vol.37
, pp. 581-587
-
-
Horai, Y.1
Fujita, K.2
Ishizaki, T.3
-
51
-
-
0025282664
-
Polymorphic oxidation of debrisoquine in bladder cancer
-
Benitez J, Ladero JM, Fernandez-Gundin MJ et al (1990): Polymorphic oxidation of debrisoquine in bladder cancer. Ann Med 22:157-160
-
(1990)
Ann Med
, vol.22
, pp. 157-160
-
-
Benitez, J.1
Ladero, J.M.2
Fernandez-Gundin, M.J.3
-
53
-
-
0033887223
-
CYP2D6 gene polymorphism in Caucasian smokers: Lung cancer susceptibility and phenotype-genotype relationships
-
Laforest L, Wikman H, Benhamou S, Saarikoski ST, Bouchardy C, Hirvonen A, Dayer P & Husgafvel-Pursiainen K (2000): CYP2D6 gene polymorphism in Caucasian smokers: lung cancer susceptibility and phenotype-genotype relationships. Eur J Cancer 36: 1825-1832
-
(2000)
Eur J Cancer
, vol.36
, pp. 1825-1832
-
-
Laforest, L.1
Wikman, H.2
Benhamou, S.3
Saarikoski, S.T.4
Bouchardy, C.5
Hirvonen, A.6
Dayer, P.7
Husgafvel-Pursiainen, K.8
-
54
-
-
0028866324
-
Polymorphisms in drug-metabolizing enzymes as modifiers of cancer risk
-
Spurr NK, Gough AC, Chinegwundoh FI & Smith CA (1995): Polymorphisms in drug-metabolizing enzymes as modifiers of cancer risk. Clin Chem 41: 1864-1869
-
(1995)
Clin Chem
, vol.41
, pp. 1864-1869
-
-
Spurr, N.K.1
Gough, A.C.2
Chinegwundoh, F.I.3
Smith, C.A.4
-
55
-
-
0029833473
-
Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients
-
Anwar WA, Abdel-Rahman SZ, El-Zein RA, Mostafa HM & Au WW (1996): Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 17: 1923-1929
-
(1996)
Carcinogenesis
, vol.17
, pp. 1923-1929
-
-
Anwar, W.A.1
Abdel-Rahman, S.Z.2
El-Zein, R.A.3
Mostafa, H.M.4
Au, W.W.5
-
56
-
-
0026776502
-
Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility
-
Wolf CR, Smith CA, Gough AC et al (1992): Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility. Carcinogenesis 13: 1035-1038
-
(1992)
Carcinogenesis
, vol.13
, pp. 1035-1038
-
-
Wolf, C.R.1
Smith, C.A.2
Gough, A.C.3
-
57
-
-
0030406977
-
Polymorphism and smoking in bladder Carcinogenesis
-
Chinegwundoh FI & Kaisary AV (1996) Polymorphism and smoking in bladder Carcinogenesis. Br J Urol 77: 672-675
-
(1996)
Br J Urol
, vol.77
, pp. 672-675
-
-
Chinegwundoh, F.I.1
Kaisary, A.V.2
-
58
-
-
0033916349
-
Cytochrome P450 2E1: Its clinical and toxicological role
-
Tanaka E, Terada M & Misawa S (2000): Cytochrome P450 2E1: its clinical and toxicological role. J Clin Pharm Ther 25: 165-175
-
(2000)
J Clin Pharm Ther
, vol.25
, pp. 165-175
-
-
Tanaka, E.1
Terada, M.2
Misawa, S.3
-
60
-
-
0025907246
-
Two common RFLPs of the human CYP2E gene
-
Uematsu F, Kikuchi H, Ohmachi T, Sagami I, Motomiya M, Kamataki T, Komori M & Watanabe M (1991): Two common RFLPs of the human CYP2E gene. Nucleic Acids Res 19: 2803
-
(1991)
Nucleic Acids Res
, vol.19
, pp. 2803
-
-
Uematsu, F.1
Kikuchi, H.2
Ohmachi, T.3
Sagami, I.4
Motomiya, M.5
Kamataki, T.6
Komori, M.7
Watanabe, M.8
-
61
-
-
0031709157
-
CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations
-
Farker K, Lehmann MH, Kastner R, Hoffmann A, Janitzky V, Schubert J, Matz U & Hofmann W (1998): CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations. Int J Clin Pharmacol Ther 36: 463-468
-
(1998)
Int J Clin Pharmacol Ther
, vol.36
, pp. 463-468
-
-
Farker, K.1
Lehmann, M.H.2
Kastner, R.3
Hoffmann, A.4
Janitzky, V.5
Schubert, J.6
Matz, U.7
Hofmann, W.8
-
62
-
-
0033969112
-
Analysis of point mutation in exon 2 of CYP2E1 gene in renal cell/urothelial cancer patients in comparison with control population
-
Farker K, Lehmann MH, Kastner R, Weber J, Janitzky V, Schubert J & Hoffmann A (2000): Analysis of point mutation in exon 2 of CYP2E1 gene in renal cell/urothelial cancer patients in comparison with control population. Int J Clin Pharmacol Ther 38: 30-34
-
(2000)
Int J Clin Pharmacol Ther
, vol.38
, pp. 30-34
-
-
Farker, K.1
Lehmann, M.H.2
Kastner, R.3
Weber, J.4
Janitzky, V.5
Schubert, J.6
Hoffmann, A.7
-
63
-
-
0029561598
-
The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance
-
Hayes JD & Pulford DJ (1995): The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600
-
(1995)
Crit Rev Biochem Mol Biol
, vol.30
, pp. 445-600
-
-
Hayes, J.D.1
Pulford, D.J.2
-
64
-
-
0026532612
-
-
Mannervik B, Awasthi YC, Board et al (1992): Nomenclature for human glutathione transferases. Biochem J 282 (Pt 1): 305-306
-
Mannervik B, Awasthi YC, Board PG et al (1992): Nomenclature for human glutathione transferases. Biochem J 282 (Pt 1): 305-306
-
-
-
-
65
-
-
0010325553
-
Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion
-
Seidegard J, Vorachek WR, Pero RW & Pearson WR (1988): Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 85: 7293-7297
-
(1988)
Proc Natl Acad Sci USA
, vol.85
, pp. 7293-7297
-
-
Seidegard, J.1
Vorachek, W.R.2
Pero, R.W.3
Pearson, W.R.4
-
66
-
-
0027370757
-
Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer
-
Zhong S, Wyllie AH, Barnes D, Wolf CR & Spurr NK (1993): Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14: 1821-1824
-
(1993)
Carcinogenesis
, vol.14
, pp. 1821-1824
-
-
Zhong, S.1
Wyllie, A.H.2
Barnes, D.3
Wolf, C.R.4
Spurr, N.K.5
-
67
-
-
0027205426
-
Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer
-
Daly AK, Thomas DJ, Cooper J, Pearson WR, Neal DE & Idle JR (1993): Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer. BMJ 307: 481-482
-
(1993)
BMJ
, vol.307
, pp. 481-482
-
-
Daly, A.K.1
Thomas, D.J.2
Cooper, J.3
Pearson, W.R.4
Neal, D.E.5
Idle, J.R.6
-
68
-
-
0027389018
-
Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers
-
Lafuente A, Pujol F, Carretero P, Villa JP & Cuchi A (1993): Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett 68: 49-54
-
(1993)
Cancer Lett
, vol.68
, pp. 49-54
-
-
Lafuente, A.1
Pujol, F.2
Carretero, P.3
Villa, J.P.4
Cuchi, A.5
-
69
-
-
0027306050
-
Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer
-
Bell DA, Taylor JA, Paulson DF, Robertson CN, Monier JL & Lucier GW (1993): Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85: 1159-1164
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 1159-1164
-
-
Bell, D.A.1
Taylor, J.A.2
Paulson, D.F.3
Robertson, C.N.4
Monier, J.L.5
Lucier, G.W.6
-
70
-
-
0028179828
-
Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility
-
Lin HJ, Han CY, Bernstein DA, Hsiao W, Lin BK & Hardy S (1994): Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 15: 1077-1081
-
(1994)
Carcinogenesis
, vol.15
, pp. 1077-1081
-
-
Lin, H.J.1
Han, C.Y.2
Bernstein, D.A.3
Hsiao, W.4
Lin, B.K.5
Hardy, S.6
-
71
-
-
0028071251
-
Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: A case-control study
-
Brockmoller J, Kerb R, Drakoulis N, Staffeldt B & Roots I (1994): Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res 54: 4103-4111
-
(1994)
Cancer Res
, vol.54
, pp. 4103-4111
-
-
Brockmoller, J.1
Kerb, R.2
Drakoulis, N.3
Staffeldt, B.4
Roots, I.5
-
72
-
-
16144362332
-
The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts
-
Rothman N, Hayes RB, Zenser TV et al (1996): The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts. Cancer Epidemiol Biomarkers Prev 5: 979-983
-
(1996)
Cancer Epidemiol Biomarkers Prev
, vol.5
, pp. 979-983
-
-
Rothman, N.1
Hayes, R.B.2
Zenser, T.V.3
-
73
-
-
0029777386
-
Influence of smoking in the glutathione-S-transferase M1 deficiency-associated risk for squamous cell carcinoma of the bladder in schistosomiasis patients in Egypt
-
Lafuente A, Zakahary MM, el-Aziz MA, Ascaso C, Lafuente MJ, Trias M & Carretero P (1996): Influence of smoking in the glutathione-S-transferase M1 deficiency-associated risk for squamous cell carcinoma of the bladder in schistosomiasis patients in Egypt. Br J Cancer 74: 836-838
-
(1996)
Br J Cancer
, vol.74
, pp. 836-838
-
-
Lafuente, A.1
Zakahary, M.M.2
el-Aziz, M.A.3
Ascaso, C.4
Lafuente, M.J.5
Trias, M.6
Carretero, P.7
-
74
-
-
0029988827
-
Glutathione S-transferase mu as a risk factor in bladder tumours
-
Okkels H, Sigsgaard T, Wolf H & Autrup H (1996): Glutathione S-transferase mu as a risk factor in bladder tumours. Pharmacogenetics 6: 251-256
-
(1996)
Pharmacogenetics
, vol.6
, pp. 251-256
-
-
Okkels, H.1
Sigsgaard, T.2
Wolf, H.3
Autrup, H.4
-
75
-
-
0029805832
-
Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder
-
Kempkes M, Golka K, Reich S, Reckwitz T & Bolt HM (1996): Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder. Arch Toxicol 71: 123-126
-
(1996)
Arch Toxicol
, vol.71
, pp. 123-126
-
-
Kempkes, M.1
Golka, K.2
Reich, S.3
Reckwitz, T.4
Bolt, H.M.5
-
76
-
-
0031945060
-
GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer
-
Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM & Au WW (1998): GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 22: 129-138
-
(1998)
Cancer Detect Prev
, vol.22
, pp. 129-138
-
-
Abdel-Rahman, S.Z.1
Anwar, W.A.2
Abdel-Aal, W.E.3
Mostafa, H.M.4
Au, W.W.5
-
77
-
-
0032561158
-
Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk
-
Katoh T, Inatomi H, Kim H, Yang M, Matsumoto T & Kawamoto T (1998): Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk. Cancer Lett 132: 147-152
-
(1998)
Cancer Lett
, vol.132
, pp. 147-152
-
-
Katoh, T.1
Inatomi, H.2
Kim, H.3
Yang, M.4
Matsumoto, T.5
Kawamoto, T.6
-
78
-
-
0033381747
-
The role of human glutathione S-transferases M1 and T1 in individual susceptibility to bladder cancer
-
Salagovic J, Kalina I, Habalova V, Hrivnak M, Valansky L & Biros E (1999): The role of human glutathione S-transferases M1 and T1 in individual susceptibility to bladder cancer. Physiol Res 48: 465-471
-
(1999)
Physiol Res
, vol.48
, pp. 465-471
-
-
Salagovic, J.1
Kalina, I.2
Habalova, V.3
Hrivnak, M.4
Valansky, L.5
Biros, E.6
-
79
-
-
0034099350
-
Glutathione S-transferase null genotypes in transitional cell bladder cancer: A case-control study
-
Georgiou I, Filiadis F, Alamanos Y, Bouha I, Giannakopoulos X & Lolis D (2000): Glutathione S-transferase null genotypes in transitional cell bladder cancer: a case-control study. Eur Urol 37: 660-664
-
(2000)
Eur Urol
, vol.37
, pp. 660-664
-
-
Georgiou, I.1
Filiadis, F.2
Alamanos, Y.3
Bouha, I.4
Giannakopoulos, X.5
Lolis, D.6
-
80
-
-
0033948966
-
Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis
-
Kim WJ, Lee HL, Lee SC, Kim YT & Kim H (2000): Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis. J Urol 164: 209-213
-
(2000)
J Urol
, vol.164
, pp. 209-213
-
-
Kim, W.J.1
Lee, H.L.2
Lee, S.C.3
Kim, Y.T.4
Kim, H.5
-
81
-
-
0034110882
-
Impact of polymorphisms in xeno(endo)biotic metabolism on pattern and frequency of p53 mutations in bladder cancer
-
Martone T, Vineis P, Malaveille C & Terracini B (2000): Impact of polymorphisms in xeno(endo)biotic metabolism on pattern and frequency of p53 mutations in bladder cancer. Mutat Res 462: 303-309
-
(2000)
Mutat Res
, vol.462
, pp. 303-309
-
-
Martone, T.1
Vineis, P.2
Malaveille, C.3
Terracini, B.4
-
82
-
-
0034070726
-
A germline homozygote deletion of the glutathione-S-transferase Mul gene predisposes to bladder cancer
-
Mungan NA, Aben KK, Beeks E, Kampman E, Bunschoten A, Bussemakers M, Witjes JA & Kiemeney LA (2000): A germline homozygote deletion of the glutathione-S-transferase Mul gene predisposes to bladder cancer. Urol Int 64: 134-138
-
(2000)
Urol Int
, vol.64
, pp. 134-138
-
-
Mungan, N.A.1
Aben, K.K.2
Beeks, E.3
Kampman, E.4
Bunschoten, A.5
Bussemakers, M.6
Witjes, J.A.7
Kiemeney, L.A.8
-
83
-
-
0033952562
-
White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer
-
Peluso M, Airoldi L, Magagnotti C, Fiorini L, Munnia A, Hautefeuille A, Malaveille C & Vineis P (2000): White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer. Carcinogenesis 21: 183-187
-
(2000)
Carcinogenesis
, vol.21
, pp. 183-187
-
-
Peluso, M.1
Airoldi, L.2
Magagnotti, C.3
Fiorini, L.4
Munnia, A.5
Hautefeuille, A.6
Malaveille, C.7
Vineis, P.8
-
84
-
-
0034052319
-
Gender-specific effects of NAT2 and GSTM1 in bladder cancer
-
Schnakenberg E, Lustig M, Breuer R, Werdin R, Hubotter R, Dreikorn K & Schloot W (2000): Gender-specific effects of NAT2 and GSTM1 in bladder cancer. Clin Genet 57: 270-277
-
(2000)
Clin Genet
, vol.57
, pp. 270-277
-
-
Schnakenberg, E.1
Lustig, M.2
Breuer, R.3
Werdin, R.4
Hubotter, R.5
Dreikorn, K.6
Schloot, W.7
-
85
-
-
0033679631
-
Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma
-
Steinhoff C, Franke KH, Golka K, Their R, Romer HC, Rotzel C, Ackermann R & Schulz WA (2000): Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 74: 521-526
-
(2000)
Arch Toxicol
, vol.74
, pp. 521-526
-
-
Steinhoff, C.1
Franke, K.H.2
Golka, K.3
Their, R.4
Romer, H.C.5
Rotzel, C.6
Ackermann, R.7
Schulz, W.A.8
-
86
-
-
0035074675
-
Glutathione S-transferase M1 gene polymorphism in bladder cancer patients, A marker for invasive bladder cancer
-
Aktas D, Ozen H, Atsu N, Tekin A, Sozen S & Tuncbilek E (2001): Glutathione S-transferase M1 gene polymorphism in bladder cancer patients, A marker for invasive bladder cancer. Cancer Genet Cytogenet 125: 1-4
-
(2001)
Cancer Genet Cytogenet
, vol.125
, pp. 1-4
-
-
Aktas, D.1
Ozen, H.2
Atsu, N.3
Tekin, A.4
Sozen, S.5
Tuncbilek, E.6
-
87
-
-
0034766048
-
Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population
-
Toruner GA, Akyerli C, Ucar A, Aki T, Atsu N, Ozen H, Tez M, Cetinkaya M & Ozcelik T (2001): Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch Toxicol 75: 459-464
-
(2001)
Arch Toxicol
, vol.75
, pp. 459-464
-
-
Toruner, G.A.1
Akyerli, C.2
Ucar, A.3
Aki, T.4
Atsu, N.5
Ozen, H.6
Tez, M.7
Cetinkaya, M.8
Ozcelik, T.9
-
88
-
-
18244371466
-
Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk
-
Lee SJ, Cho SH, Park SK et al (2002): Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk. Cancer Lett 177: 173-179
-
(2002)
Cancer Lett
, vol.177
, pp. 173-179
-
-
Lee, S.J.1
Cho, S.H.2
Park, S.K.3
-
89
-
-
0033828507
-
Glutathione S-transferase mul (GSTM1) status and bladder cancer risk: A meta-analysis
-
Johns LE & Houlston RS (2000): Glutathione S-transferase mul (GSTM1) status and bladder cancer risk: a meta-analysis. Mutagenesis 15: 399-404
-
(2000)
Mutagenesis
, vol.15
, pp. 399-404
-
-
Johns, L.E.1
Houlston, R.S.2
-
90
-
-
0037100373
-
Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: A HuGE review
-
Engel LS, Taioli E, Pfeiffer R et al (2002): Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 156: 95-109
-
(2002)
Am J Epidemiol
, vol.156
, pp. 95-109
-
-
Engel, L.S.1
Taioli, E.2
Pfeiffer, R.3
-
91
-
-
0031427094
-
Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer
-
Harries LW, Stubbins MJ, Forman D, Howard GC & Wolf CR (1997): Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18: 641-644
-
(1997)
Carcinogenesis
, vol.18
, pp. 641-644
-
-
Harries, L.W.1
Stubbins, M.J.2
Forman, D.3
Howard, G.C.4
Wolf, C.R.5
-
92
-
-
0032803469
-
Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer
-
Katoh T, Kaneko S, Takasawa S, Nagata N, Inatomi H, Ikemura K, Itoh H, Mastumoto T, Kawamoto T & Bell DA (1999): Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics 9: 165-169
-
(1999)
Pharmacogenetics
, vol.9
, pp. 165-169
-
-
Katoh, T.1
Kaneko, S.2
Takasawa, S.3
Nagata, N.4
Inatomi, H.5
Ikemura, K.6
Itoh, H.7
Mastumoto, T.8
Kawamoto, T.9
Bell, D.A.10
-
93
-
-
0029559744
-
Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis
-
Kadlubar FF & Badawi AF (1995): Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis. Toxicol Lett 82-83: 627-632
-
(1995)
Toxicol Lett
, vol.82-83
, pp. 627-632
-
-
Kadlubar, F.F.1
Badawi, A.F.2
-
94
-
-
0032810707
-
Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese
-
Katoh T, Inatomi H, Yang M, Kawamoto T, Matsumoto T & Bell DA (1999): Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese. Pharmacogenetics 9: 401-404
-
(1999)
Pharmacogenetics
, vol.9
, pp. 401-404
-
-
Katoh, T.1
Inatomi, H.2
Yang, M.3
Kawamoto, T.4
Matsumoto, T.5
Bell, D.A.6
-
95
-
-
0032529236
-
The role of N-acetylation polymorphisms in smoking-associated bladder cancer: Evidence of a gene-gene-exposure three-way interaction
-
Taylor JA, Umbach DM, Stephens E, Castranio T, Paulson D, Robertson C, Mohler JL & Bell DA (1998): The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res 58: 3603-3610
-
(1998)
Cancer Res
, vol.58
, pp. 3603-3610
-
-
Taylor, J.A.1
Umbach, D.M.2
Stephens, E.3
Castranio, T.4
Paulson, D.5
Robertson, C.6
Mohler, J.L.7
Bell, D.A.8
-
96
-
-
0030940149
-
Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: The influence of smoking
-
Okkels H, Sigsgaard T, Wolf H & Autrup H (1997): Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Cancer Epidemiol Biomarkers Prev 6: 225-231
-
(1997)
Cancer Epidemiol Biomarkers Prev
, vol.6
, pp. 225-231
-
-
Okkels, H.1
Sigsgaard, T.2
Wolf, H.3
Autrup, H.4
-
97
-
-
0032837276
-
Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer
-
Hsieh FI, Pu YS, Chern HD, Hsu LI, Chiou HY & Chen CJ (1999): Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Br J Cancer 81: 537-541
-
(1999)
Br J Cancer
, vol.81
, pp. 537-541
-
-
Hsieh, F.I.1
Pu, Y.S.2
Chern, H.D.3
Hsu, L.I.4
Chiou, H.Y.5
Chen, C.J.6
-
98
-
-
0035393497
-
Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: Significantly reduced risk in subjects with NAT1*10
-
Cascorbi I, Roots I & Brockmoller J (2001): Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10. Cancer Res 61: 5051-5056
-
(2001)
Cancer Res
, vol.61
, pp. 5051-5056
-
-
Cascorbi, I.1
Roots, I.2
Brockmoller, J.3
-
99
-
-
0018330592
-
N-acetyl-transferase phenotype and risk in urinary bladder cancer: Approaches in molecular epidemiology. Preliminary results in Sweden and Denmark
-
Lower GM Jr, Nilsson T, Nelson CE, Wolf H, Gamsky TE & Bryan GT(1979): N-acetyl-transferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environ Health Perspect 29: 71-79
-
(1979)
Environ Health Perspect
, vol.29
, pp. 71-79
-
-
Lower Jr, G.M.1
Nilsson, T.2
Nelson, C.E.3
Wolf, H.4
Gamsky, T.E.5
Bryan, G.T.6
-
100
-
-
0019191532
-
Role of N-acetyltransferase phenotype in human susceptibility to bladder carcinogenic arylamines
-
Wolf H, Lower GM & Bryan GT Jr (1980): Role of N-acetyltransferase phenotype in human susceptibility to bladder carcinogenic arylamines. Scand J Urol Nephrol 14: 161-165
-
(1980)
Scand J Urol Nephrol
, vol.14
, pp. 161-165
-
-
Wolf, H.1
Lower, G.M.2
Bryan Jr, G.T.3
-
101
-
-
0019976311
-
Role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer
-
Cartwright RA, Glashan RW, Rogers HJ, Ahmad RA, Barham-Hall D, Higgins E & Kahn MA (1982): Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 8303: 842-845
-
(1982)
Lancet
, vol.8303
, pp. 842-845
-
-
Cartwright, R.A.1
Glashan, R.W.2
Rogers, H.J.3
Ahmad, R.A.4
Barham-Hall, D.5
Higgins, E.6
Kahn, M.A.7
-
102
-
-
0020601991
-
The association of the slow acetylator phenotype with bladder cancer
-
Evans DA, Eze LC & Whibley EJ (1983): The association of the slow acetylator phenotype with bladder cancer. J Med Genet 20: 330-333
-
(1983)
J Med Genet
, vol.20
, pp. 330-333
-
-
Evans, D.A.1
Eze, L.C.2
Whibley, E.J.3
-
103
-
-
0020565848
-
Acetylator phenotype in human bladder cancer
-
Miller ME & Cosgriff JM (1983): Acetylator phenotype in human bladder cancer. J Urol 130: 65-66
-
(1983)
J Urol
, vol.130
, pp. 65-66
-
-
Miller, M.E.1
Cosgriff, J.M.2
-
104
-
-
85039131336
-
-
Cartwright R (1984): Epidemiologic studies on N-acetylation and C-center ring oxidation in neoplasia. In: Banbury Report 16: Genetic Variability in Responses to Chemical Exposure, (Omenn GS, Gelboin HV, ed). Cold Spring Harbor Laboratory, Cold Spring Harbor pp359-368
-
Cartwright R (1984): Epidemiologic studies on N-acetylation and C-center ring oxidation in neoplasia. In: Banbury Report 16: Genetic Variability in Responses to Chemical Exposure, (Omenn GS, Gelboin HV, ed). Cold Spring Harbor Laboratory, Cold Spring Harbor pp359-368
-
-
-
-
105
-
-
0021794814
-
Association of N-acetyltransferase polymorphism and environmental factors with bladder carcinogenesis. Study in a north German population
-
Hanssen HP, Agarwal DP, Goedde HW, Bucher H, Huland H, Brachmann W & Ovenbeck R (1985): Association of N-acetyltransferase polymorphism and environmental factors with bladder carcinogenesis. Study in a north German population. Eur Urol 11: 263-266
-
(1985)
Eur Urol
, vol.11
, pp. 263-266
-
-
Hanssen, H.P.1
Agarwal, D.P.2
Goedde, H.W.3
Bucher, H.4
Huland, H.5
Brachmann, W.6
Ovenbeck, R.7
-
106
-
-
0021839063
-
Hepatic acetylator phenotype in bladder cancer patients
-
Ladero JM, Kwok CK, Jara C, Fernandez L, Silmi AM, Tapia D & Uson AC (1985): Hepatic acetylator phenotype in bladder cancer patients. Ann Clin Res 17: 96-99
-
(1985)
Ann Clin Res
, vol.17
, pp. 96-99
-
-
Ladero, J.M.1
Kwok, C.K.2
Jara, C.3
Fernandez, L.4
Silmi, A.M.5
Tapia, D.6
Uson, A.C.7
-
107
-
-
0021931373
-
N-acetyltransferase phenotypes in the urinary bladder carcinogenesis of a low-risk population
-
Mommsen S, Barfod NM & Aagaard J (1985): N-acetyltransferase phenotypes in the urinary bladder carcinogenesis of a low-risk population. Carcinogenesis 6: 199-201
-
(1985)
Carcinogenesis
, vol.6
, pp. 199-201
-
-
Mommsen, S.1
Barfod, N.M.2
Aagaard, J.3
-
108
-
-
0022468570
-
N-acetyltransferase phenotype of patients with bladder cancer
-
Karakaya AE, Cok I, Sardas S, Gogus O & Sardas OS (1986): N-acetyltransferase phenotype of patients with bladder cancer. Hum Toxicol 5: 333-335
-
(1986)
Hum Toxicol
, vol.5
, pp. 333-335
-
-
Karakaya, A.E.1
Cok, I.2
Sardas, S.3
Gogus, O.4
Sardas, O.S.5
-
109
-
-
0023193252
-
Genetic predisposition to bladder cancer: Ability to hydroxylate debrisoquine and mephenytoin as risk factors
-
Kaisary A, Smith P, Jaczq E, McAllister CB, Wilkinson GR, Ray WA & Branch RA (1987): Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors. Cancer Res 47: 5488-5493
-
(1987)
Cancer Res
, vol.47
, pp. 5488-5493
-
-
Kaisary, A.1
Smith, P.2
Jaczq, E.3
McAllister, C.B.4
Wilkinson, G.R.5
Ray, W.A.6
Branch, R.A.7
-
111
-
-
0024817873
-
Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer
-
Horai Y, Fujita K & Ishizaki T (1989): Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer. Eur J Clin Pharmacol 37: 581-587
-
(1989)
Eur J Clin Pharmacol
, vol.37
, pp. 581-587
-
-
Horai, Y.1
Fujita, K.2
Ishizaki, T.3
-
112
-
-
0024997081
-
Acetylation phenotypes and bladder cancer
-
Hanke J & Krajewska B (1990): Acetylation phenotypes and bladder cancer. J Occup Med 32: 917-918
-
(1990)
J Occup Med
, vol.32
, pp. 917-918
-
-
Hanke, J.1
Krajewska, B.2
-
113
-
-
0027289094
-
N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers
-
Hayes RB, Bi W, Rothman N, Broly F, Caporaso N, Feng P, You X, Yin S, Woosley RL & Meyer UA (1993): N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. Carcinogenesis 14: 675-678
-
(1993)
Carcinogenesis
, vol.14
, pp. 675-678
-
-
Hayes, R.B.1
Bi, W.2
Rothman, N.3
Broly, F.4
Caporaso, N.5
Feng, P.6
You, X.7
Yin, S.8
Woosley, R.L.9
Meyer, U.A.10
-
114
-
-
0029260992
-
N-acetyltransferase activity - a susceptibility factor in human bladder carcinogenesis
-
Dewan A, Chattopadhyay P & Kulkarni PK (1995): N-acetyltransferase activity - a susceptibility factor in human bladder carcinogenesis. Indian J Cancer 32: 15-19
-
(1995)
Indian J Cancer
, vol.32
, pp. 15-19
-
-
Dewan, A.1
Chattopadhyay, P.2
Kulkarni, P.K.3
-
115
-
-
0029417259
-
N-acetyltransferase activity in the urine in Japanese subjects: Comparison in healthy persons and bladder cancer patients
-
Ishizu S, Hashida C, Hanaoka T, Maeda K & Ohishi Y (1995): N-acetyltransferase activity in the urine in Japanese subjects: comparison in healthy persons and bladder cancer patients. Jpn J Cancer Res 86: 1179-1181
-
(1995)
Jpn J Cancer Res
, vol.86
, pp. 1179-1181
-
-
Ishizu, S.1
Hashida, C.2
Hanaoka, T.3
Maeda, K.4
Ohishi, Y.5
-
116
-
-
0028909978
-
Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer
-
Risen A, Wallace DM, Bathers S & Sim E (1995): Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet 4: 231-236
-
(1995)
Hum Mol Genet
, vol.4
, pp. 231-236
-
-
Risen, A.1
Wallace, D.M.2
Bathers, S.3
Sim, E.4
-
117
-
-
0029827668
-
Occupational history and genetic N-acetyltransferase polymorphism in urothelial cancer patients of Leverkusen, Germany
-
Golka K, Prior V, Blaszkewicz M, Cascorbi I, Schops W, Kierfeld G, Roots I & Bolt HM (1996): Occupational history and genetic N-acetyltransferase polymorphism in urothelial cancer patients of Leverkusen, Germany. Scand J Work Environ Health 22: 332-338
-
(1996)
Scand J Work Environ Health
, vol.22
, pp. 332-338
-
-
Golka, K.1
Prior, V.2
Blaszkewicz, M.3
Cascorbi, I.4
Schops, W.5
Kierfeld, G.6
Roots, I.7
Bolt, H.M.8
-
118
-
-
0030940149
-
Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: The influence of smoking
-
Okkels H, Sigsgaard T, Wolf H & Autrup H (1997): Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Cancer Epidemiol Biomarkers Prev 6: 225-231
-
(1997)
Cancer Epidemiol Biomarkers Prev
, vol.6
, pp. 225-231
-
-
Okkels, H.1
Sigsgaard, T.2
Wolf, H.3
Autrup, H.4
-
119
-
-
7344242589
-
White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: A case-control study
-
Peluso M, Airoldi L, Armelle M, Martone T, Coda R, Malaveille C, Giacomelli G, Terrone C, Casetta G & Vineis P (1998): White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 7: 341-346
-
(1998)
Cancer Epidemiol Biomarkers Prev
, vol.7
, pp. 341-346
-
-
Peluso, M.1
Airoldi, L.2
Armelle, M.3
Martone, T.4
Coda, R.5
Malaveille, C.6
Giacomelli, G.7
Terrone, C.8
Casetta, G.9
Vineis, P.10
-
120
-
-
0031777497
-
Genotyping of the polymorphic N-acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer patients
-
Schnakenberg E, Ehlers C, Feyerabend W, Werdin R, Hubotter R, Dreikorn K & Schloot W (1998): Genotyping of the polymorphic N-acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer patients. Clin Genet 53: 396-402
-
(1998)
Clin Genet
, vol.53
, pp. 396-402
-
-
Schnakenberg, E.1
Ehlers, C.2
Feyerabend, W.3
Werdin, R.4
Hubotter, R.5
Dreikorn, K.6
Schloot, W.7
-
121
-
-
0031593338
-
The NAT2* slow acetylator genotype is associated with bladder cancer in Taiwanese, but not in the black foot disease endemic area population
-
Su HJ, Guo YL, Lai MD, Huang JD, Cheng Y & Christiani DC (1998): The NAT2* slow acetylator genotype is associated with bladder cancer in Taiwanese, but not in the black foot disease endemic area population. Pharmacogenetics 8: 187-190
-
(1998)
Pharmacogenetics
, vol.8
, pp. 187-190
-
-
Su, H.J.1
Guo, Y.L.2
Lai, M.D.3
Huang, J.D.4
Cheng, Y.5
Christiani, D.C.6
-
122
-
-
0032529236
-
The role of N-acetylation polymorphisms in smoking-associated bladder cancer: Evidence of a gene-gene-exposure three-way interaction
-
Taylor JA, Umbach DM, Stephens E, Castranio T, Paulson D, Robertson C, Mohler JL & Bell DA (1998): The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res 58: 3603-3610
-
(1998)
Cancer Res
, vol.58
, pp. 3603-3610
-
-
Taylor, J.A.1
Umbach, D.M.2
Stephens, E.3
Castranio, T.4
Paulson, D.5
Robertson, C.6
Mohler, J.L.7
Bell, D.A.8
-
123
-
-
0032850119
-
Genotypes of N-acetyltransferase-2 and risk of bladder cancer: A case-control study
-
Filiadis IF, Georgiou I, Alamanos Y, Kranas V, Giannakopoulos X & Lolis D (1999): Genotypes of N-acetyltransferase-2 and risk of bladder cancer: a case-control study. J Urol 161: 1672-1675
-
(1999)
J Urol
, vol.161
, pp. 1672-1675
-
-
Filiadis, I.F.1
Georgiou, I.2
Alamanos, Y.3
Kranas, V.4
Giannakopoulos, X.5
Lolis, D.6
-
124
-
-
0032833244
-
NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese
-
Inatomi H, Katoh T, Kawamoto T & Matsumoto T (1999): NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese. Int J Urol 6: 446-454
-
(1999)
Int J Urol
, vol.6
, pp. 446-454
-
-
Inatomi, H.1
Katoh, T.2
Kawamoto, T.3
Matsumoto, T.4
-
125
-
-
0035393497
-
Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer, significantly reduced risk in subjects with NAT1*10
-
Cascorbi I, Roots I & Brockmoller J (2001): Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer, significantly reduced risk in subjects with NAT1*10. Cancer Res 61: 5051-5056
-
(2001)
Cancer Res
, vol.61
, pp. 5051-5056
-
-
Cascorbi, I.1
Roots, I.2
Brockmoller, J.3
-
126
-
-
0034946725
-
Tobacco use and occupational exposure to carcinogens, but not N-acetyltransferase 2 genotypes are major risk factors for bladder cancer in the Japanese
-
Kontani K, Kawakami M, Nakajima T & Katsuyama T (2001): Tobacco use and occupational exposure to carcinogens, but not N-acetyltransferase 2 genotypes are major risk factors for bladder cancer in the Japanese. Urol Res 29: 199-204
-
(2001)
Urol Res
, vol.29
, pp. 199-204
-
-
Kontani, K.1
Kawakami, M.2
Nakajima, T.3
Katsuyama, T.4
-
127
-
-
0033938764
-
N-acetyltransferase 2 and bladder cancer: An overview and consideration of the evidence for gene-environment interaction
-
Green J, Banks E, Berrington A, Darby S, Deo H & Newton R (2000): N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction. Br J Cancer 83: 412-417
-
(2000)
Br J Cancer
, vol.83
, pp. 412-417
-
-
Green, J.1
Banks, E.2
Berrington, A.3
Darby, S.4
Deo, H.5
Newton, R.6
-
128
-
-
0033764720
-
N-acetyl transferase-2 and bladder cancer risk: A meta-analysis
-
Johns LE & Houlston RS (2000): N-acetyl transferase-2 and bladder cancer risk: a meta-analysis. Environ Mol Mutagen 36: 221-227
-
(2000)
Environ Mol Mutagen
, vol.36
, pp. 221-227
-
-
Johns, L.E.1
Houlston, R.S.2
-
129
-
-
0034027832
-
NAT2 slow acetylation and bladder cancer risk: A meta-analysis of 22 case-control studies conducted in the general population
-
Marcus PM, Vineis P & Rothman N (2000): NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population. Pharmacogenetics 10: 115-122
-
(2000)
Pharmacogenetics
, vol.10
, pp. 115-122
-
-
Marcus, P.M.1
Vineis, P.2
Rothman, N.3
-
130
-
-
18844480807
-
Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: A case-series meta-analysis of a gene-environment interaction
-
Marcus PM, Hayes RB, Vineis P et al (2000): Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev 9: 461-467
-
(2000)
Cancer Epidemiol Biomarkers Prev
, vol.9
, pp. 461-467
-
-
Marcus, P.M.1
Hayes, R.B.2
Vineis, P.3
-
131
-
-
0035660127
-
Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: A pooled analysis of genotype-based studies
-
Vineis P, Marinelli D, Autrup H et al (2001): Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev 10: 1249-1252
-
(2001)
Cancer Epidemiol Biomarkers Prev
, vol.10
, pp. 1249-1252
-
-
Vineis, P.1
Marinelli, D.2
Autrup, H.3
-
132
-
-
2442709151
-
GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population
-
Hung RJ, Boffetta P & Brennan P et al (2004): GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 110: 598-604
-
(2004)
Int J Cancer
, vol.110
, pp. 598-604
-
-
Hung, R.J.1
Boffetta, P.2
Brennan, P.3
-
133
-
-
1542373500
-
Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer
-
Tsukino H, Kuroda Y, Nakao H, Imai H, Inatomi H, Osada Y & Katoh T (2004): Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer. J Cancer Res Clin Oncol 130: 99-106
-
(2004)
J Cancer Res Clin Oncol
, vol.130
, pp. 99-106
-
-
Tsukino, H.1
Kuroda, Y.2
Nakao, H.3
Imai, H.4
Inatomi, H.5
Osada, Y.6
Katoh, T.7
-
134
-
-
0033984936
-
Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers
-
Bartsch H, Nair U, Risch A, Rojas M, Wikman H & Alexandrov K (2000): Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 9: 3-28
-
(2000)
Cancer Epidemiol Biomarkers Prev
, vol.9
, pp. 3-28
-
-
Bartsch, H.1
Nair, U.2
Risch, A.3
Rojas, M.4
Wikman, H.5
Alexandrov, K.6
|